Phase 2 Adenocarcinoma of Esophagogastric Junction Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
Siewert Type II Adenocarcinoma of Esophagogastric JunctionAdenocarcinoma EsophagusLocally Advanced Adenocarcinoma+1 more
Sakti Chakrabarti25 enrolled1 locationNCT06044311
Recruiting
Phase 2
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
HER2-positive Gastric CancerAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Yu jiren30 enrolled8 locationsNCT05715931
Recruiting
Phase 2
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionProficient Mismatch Repair
Yu jiren314 enrolled5 locationsNCT05872685
Recruiting
Phase 2
Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Mismatch Repair DeficiencyAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Yu jiren90 enrolled8 locationsNCT05729646